Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 2
2013 2
2014 2
2016 1
2017 1
2018 2
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic Targeting of Collective Invasion in Ovarian Cancer.
Moffitt L, Karimnia N, Stephens A, Bilandzic M. Moffitt L, et al. Among authors: Bilandzic M. Int J Mol Sci. 2019 Mar 22;20(6):1466. doi: 10.3390/ijms20061466. Int J Mol Sci. 2019. PMID: 30909510 Free PMC article. Review.
Non-Invasive Fluorescent Monitoring of Ovarian Cancer in an Immunocompetent Mouse Model.
Wilson AL, Wilson KL, Bilandzic M, Moffitt LR, Makanji M, Gorrell MD, Oehler MK, Rainczuk A, Stephens AN, Plebanski M. Wilson AL, et al. Among authors: Bilandzic M. Cancers (Basel). 2018 Dec 31;11(1):32. doi: 10.3390/cancers11010032. Cancers (Basel). 2018. PMID: 30602661 Free PMC article.
Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine.
Sandow JJ, Rainczuk A, Infusini G, Makanji M, Bilandzic M, Wilson AL, Fairweather N, Stanton PG, Garama D, Gough D, Jobling TW, Webb AI, Stephens AN. Sandow JJ, et al. Among authors: Bilandzic M. Proteomics Clin Appl. 2018 May;12(3):e1700135. doi: 10.1002/prca.201700135. Epub 2018 Mar 2. Proteomics Clin Appl. 2018. PMID: 29426060
Betaglycan: a multifunctional accessory.
Bilandzic M, Stenvers KL. Bilandzic M, et al. Mol Cell Endocrinol. 2011 Jun 6;339(1-2):180-9. doi: 10.1016/j.mce.2011.04.014. Epub 2011 Apr 28. Mol Cell Endocrinol. 2011. PMID: 21550381 Review.
Reprint of: Betaglycan: a multifunctional accessory.
Bilandzic M, Stenvers KL. Bilandzic M, et al. Mol Cell Endocrinol. 2012 Aug 15;359(1-2):13-22. doi: 10.1016/j.mce.2012.03.020. Epub 2012 Apr 13. Mol Cell Endocrinol. 2012. PMID: 22521265
Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling.
Samardzija C, Greening DW, Escalona R, Chen M, Bilandzic M, Luwor R, Kannourakis G, Findlay JK, Ahmed N. Samardzija C, et al. Among authors: Bilandzic M. Sci Rep. 2017 Apr 13;7:46312. doi: 10.1038/srep46312. Sci Rep. 2017. PMID: 28406185 Free PMC article.
Increasing intracellular bioavailable copper selectively targets prostate cancer cells.
Cater MA, Pearson HB, Wolyniec K, Klaver P, Bilandzic M, Paterson BM, Bush AI, Humbert PO, La Fontaine S, Donnelly PS, Haupt Y. Cater MA, et al. Among authors: Bilandzic M. ACS Chem Biol. 2013 Jul 19;8(7):1621-31. doi: 10.1021/cb400198p. Epub 2013 May 24. ACS Chem Biol. 2013. PMID: 23656859
15 results
Jump to page